Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 53, Issue 9, 2012, Pages 1807-1810

  Perry, Chava ^a   Herishanu, Yair ^a   Hazan Halevy, Inbal ^a   Kay, Sigi ^a   Bdolach, Nir ^b   Naparstek, Elizabeth ^a   Polliack, Aaron ^a,c   Grisaru, Dan ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b LIS MATERNITY HOSPITAL   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANALYSIS OF VARIANCE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CELL POPULATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEART RATE; HUMAN; HUMAN CELL; INFORMED CONSENT; LETTER; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; TREADMILL EXERCISE;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84865004942     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.656634     Document Type: Letter

References (9)

1. Byrd JC, Stilgenbauer S, Flinn IW. Chronic lymphocytic leukemia. Hematology 2004;2004:163-183.
2. Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Invest 2007;117:1167-1174.
3. Z heng SG, Wang J, Wang P, et al. IL-2 is essential for TGF-beta to convert naive CD4-CD25- cells to CD25-Foxp3-regulatory T cells and for expansion of these cells. J Immunol 2007;178:2018-2027.
4. B eyer M, Schultze JL. Regulatory T cells in cancer. Blood 2006;108:804-811.
5. Muranski P, Boni A, Antony PA, et al. Tumor-specifi c Th17-polarized cells eradicate large established melanoma. Blood 2008;112:362-373.
6. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic eff ector TH17 and regulatory T cells. Nature 2006;441:235-238.
7. B ernstein L. Identifying population-based approaches to lower breast cancer risk. Oncogene 2008;27(Suppl. 2):S3-S8.
8. Idler I, Giannopoulos K, Zenz T, et al. Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells. Br J Haematol 2010;148:948-950.
9. Suzuki K, Nakaji S, Yamada M, et al. Systemic infl amatory response to exhaustive exercise. Cytokine kinetics. Exerc Immunol Rev 2002;8:6-48.